Search results
Author(s):
Iosif Xenogiannis
,
Charalampos Varlamos
,
Despoina-Rafailia Benetou
,
et al
Added:
2 years ago
Author(s):
Despoina-Rafailia Benetou
,
Panayotis K Vlachakis
,
Charalampos Varlamos
,
et al
Added:
2 years ago
Author(s):
Christopher P Cannon
Added:
6 years ago
This interview with Christopher P. Cannon from Brigham and Women's Hospital, Boston, US discusses Dual Antithrombotic Therapy with Dabigatran After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation (REDUAL-PCI).
Filmed by Radcliffe Cardiology on-site at ESC 2017.
View more
Author(s):
Charalampos Varlamos
,
Ioannis Lianos
,
Despoina-Rafailia Benetou
,
et al
Added:
2 years ago
Author(s):
David Berg
Added:
1 year ago
ESC Congress 22 — Dr David Berg (Brigham and Women's Hospital, US) shares key results from the TIMI Study Group's COVID-PACT trial (NCT04409834).
This multicenter, randomized-controlled trial assessed efficacy and safety of full-dose vs. standard prophylactic dose anticoagulation and of antiplatelet vs. no antiplatelet therapy for prevention of venous and arterial thrombotic events. The study…
View more
Author(s):
George D Dangas
Added:
2 years ago
In this short video, Dr George Dangas (Mount Sinai Hospital, New York, NY, US) shares the findings from the ENVISAGE-TAVI AF hot line trial presented at ESC Congress 2021.
ENVISAGE-TAVI AF (Daiichi-Sankyo) compared the safety and efficacy of the DOAC edoxaban with VKAs (warfarin and its analogues) in atrial fibrillation patients with an indication for oral anticoagulation after successful TAVI.
…
View more
Author(s):
Philip J Devereaux
,
John Eikelboom
Added:
6 years ago
The effect of dabigatran in patients suffering myocardial injury after non-cardiac surgery - ACC 2018
An expert peer-to-peer discussion on the latest data to come out of the MANAGE trial and its implications for clinical practice.
Sunday 11th March 2018 @ 11:45 EST
ACC.18 Congress, Orlando, FL
Discussants: Dr PJ Devereaux (Ontario, US) & Dr John Eikelboom (Ontario, US)
Dr PJ…
View more
Author(s):
Otavio Berwanger
,
Prof José C Nicolau
Added:
6 years ago
Explore the safety and efficacy of ticagrelor compared with clopidogrel in patients with acute coronary syndrome with ST elevation treated with thrombolysis - ACC 2018
An expert peer-to-peer discussion on the latest data to come out of the TREAT trial and its implications for clinical practice.
Sunday 11th March 2018 @ 15:00 EST
ACC.18 Congress, Orlando, FL
Discussants: Dr Otavio Berwanger …
View more
Author(s):
Prof José C Nicolau
,
Christopher B Granger
Added:
6 years ago
Explore the safety and efficacy of ticagrelor compared with clopidogrel in patients with acute coronary syndrome with ST elevation treated with thrombolysis - ACC 2018
An expert peer-to-peer discussion on the latest data to come out of the TREAT trial and its implications for clinical practice.
Sunday 11th March 2018 @ 15:00 EST
ACC.18 Congress, Orlando, FL
Discussants: Dr Christopher Granger …
View more
Boyoung Joung
Research Area(s) / Expertise:
Author